| ISIN | LU1735538974 |
|---|---|
| Valor Number | 39255094 |
| Bloomberg Global ID | UBKEHFA LX |
| Fund Name | UBS (Lux) Key Selection SICAV - Systematic Allocation Portfolio Equity (USD) (EUR hedged) F-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
| Asset Class | Asset Allocation |
| EFC Category | Multi-Strategy ARIS |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The actively managed sub-fund uses the benchmark MSCI All Country World with Developed Markets (net div. reinvested) (hedged to USD) for performance evaluation purposes. For share classes with “hedged” in their name, currency-hedged versions of the relevant benchmark (if available) are used for performance evaluation purposes. The investments and performance of the sub-fund may differ from the benchmark. The performance of the sub-fund may therefore differ considerably from the benchmark during periods of high market volatility. The sub-fund uses a composite benchmark consisting of 36% MSCI USA Index (net div. reinvested), 12% MSCI Emerging Markets Index (net div. reinvested), 23% MSCI EMU Index (net div. reinvested) (hedged to USD), 15% MSCI United Kingdom Index (net div. reinvested) (hedged to USD), 7% MSCI Japan (net div. reinvested) (hedged to USD), and 7% MSCI Switzerland (net div. reinvested) (hedged to USD) as reference for risk management purposes. |
| Peculiarities |
| Current Price * | 128.63 EUR | 08.01.2026 |
|---|---|---|
| Previous Price * | 128.96 EUR | 07.01.2026 |
| 52 Week High * | 129.13 EUR | 06.01.2026 |
| 52 Week Low * | 96.72 EUR | 09.04.2025 |
| NAV * | 128.63 EUR | 08.01.2026 |
| Issue Price * | 128.54 EUR | 08.01.2026 |
| Redemption Price * | 128.54 EUR | 08.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 223,077,230 | |
| Unit/Share Assets *** | 45,571,032 | |
| Trading Information SIX | ||
| YTD Performance | +1.81% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +1.78% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
| 1 month | +2.70% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +4.56% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 months | +16.76% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 year | +6.81% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 years | +35.37% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 years | +49.50% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 years | +26.08% |
08.01.2021 - 08.01.2026
08.01.2021 08.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS MSCI USA SF ETF USD acc | 18.13% | |
|---|---|---|
| Invesco MSCI USA ETF | 18.07% | |
| UBS MSCI USA SF Index USD acc | 14.80% | |
| Xtrackers MSCI USA Swap ETF 1C | 13.62% | |
| E-mini S&P 500 Future Dec 25 | 0.85% | |
| United States Treasury Bills 0% | 0.61% | |
| ASML Holding NV | 0.44% | |
| AstraZeneca PLC | 0.31% | |
| Msci Emgmkt Dec25 | 0.29% | |
| Roche Holding AG | 0.29% | |
| Last data update | 30.11.2025 | |
| TER | 0.75% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | 0.00% |
| PTR | |
| Max. Management Fee *** | 0.51% |
| Ongoing Charges *** | 0.75% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |